COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 105 filers reported holding COHERUS BIOSCIENCES INC in Q1 2018. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,501,000 | +92.7% | 83,343 | +116.8% | 0.07% | +89.7% |
| Q3 2019 | $779,000 | -60.7% | 38,443 | -57.2% | 0.04% | -65.2% |
| Q2 2019 | $1,983,000 | +41.2% | 89,743 | -12.8% | 0.11% | +33.3% |
| Q1 2019 | $1,404,000 | +12.9% | 102,943 | +36.5% | 0.08% | +47.4% |
| Q3 2018 | $1,244,000 | +169.8% | 75,440 | +129.0% | 0.06% | +200.0% |
| Q2 2018 | $461,000 | +72.7% | 32,940 | +35.9% | 0.02% | +72.7% |
| Q1 2018 | $267,000 | +53.4% | 24,245 | +85.1% | 0.01% | +22.2% |
| Q3 2017 | $174,000 | -81.5% | 13,099 | -60.8% | 0.01% | -83.9% |
| Q4 2016 | $940,000 | +314.1% | 33,400 | +292.9% | 0.06% | -23.3% |
| Q3 2016 | $227,000 | – | 8,500 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |